Drugplain

EnilloRing .015 mg/d

Etonogestrel and Ethinyl Estradiol Vaginal · RING · Xiromed, LLC

No Recall HistoryCurrently in Shortage
Plain English

EnilloRing is a ring containing etonogestrel and ethinyl estradiol vaginal at .015 mg/d, taken vaginal. Manufactured by Xiromed, LLC.

Key Facts

Brand Name
EnilloRing
Generic Name
Etonogestrel and Ethinyl Estradiol Vaginal
NDC Code (Product)
70700-156
Manufacturer
Xiromed, LLC
Strength
.015 mg/d
Dosage Form
RING
Route
VAGINAL
Marketing Status
Application #
ANDA211157
Drug Class
Estrogen [EPC]; Progestin [EPC]
Marketing Start
08/15/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

intermenstrual bleeding7 reports
product substitution issue5 reports
product use in unapproved indication4 reports
device physical property issue3 reports
headache3 reports
product prescribing issue3 reports
product quality issue3 reports
vaginal discharge3 reports
device use issue2 reports
dizziness2 reports

Frequently Asked Questions

What is EnilloRing used for?

EnilloRing contains Etonogestrel and Ethinyl Estradiol Vaginal. It is a ring taken vaginal. Consult your doctor for specific uses.

Is EnilloRing a controlled substance?

EnilloRing is not classified as a controlled substance by the DEA.

What is the generic name for EnilloRing?

The generic name for EnilloRing is Etonogestrel and Ethinyl Estradiol Vaginal. There are 2 other brand versions of Etonogestrel and Ethinyl Estradiol Vaginal.

What is the NDC code for EnilloRing .015 mg/d?

The NDC (National Drug Code) for EnilloRing .015 mg/d is 70700-156, listed by Xiromed, LLC.

Product NDC

70700-156

Package NDC

70700-156-91

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)